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Abstract 
Nitrogen containing mono-heterocyclic hypervalent iodine(III) compounds, 
benziodazoles, have been investigated by several research groups as well as ours. These 
compounds are commonly used as efficient oxidative reagents for various organic 
substrates. The preparation, structure, and reactivity of the first bicyclic benziodazole 
compound, N,N’-diisopropylbenziodazole, will be reported and compared to the 
monocyclic N-isopropyl-m-chlorobenzoate benziodazole. Both benziodazoles were 
prepared by the m-chloroperoxybenzoic acid oxidation of 2-iodo-N-isopropylbenzamide or 
2-iodo-N,N’-diisiopropylisophthalamide, respectively, and their structures were 
established by X-ray crystallography. These benziodazoles were investigated as efficient 
reagents for oxidatively assisted coupling reactions to form esters and amides. 
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1. Introduction 
Iodine, the element with atomic number 53, can be found in the seventeenth period 
of the fourth row on the periodic table. Iodine, with an atomic mass of 126.9 amu, can be 
considered as the heaviest non-radioactive element among the non-metals. Among the 
halogens, iodine is the most polarizable and least electronegative. These properties allow 
iodine to exist in a variety of oxidation states, including -1, 0, +1, +3, +5, and +7.1 
Compounds shown below in Table 1 provide an example of iodine in each of these 
oxidation states. 
 
Table 1: An example of iodine in each of its oxidation states. 
 
 
Iodine species with oxidation states of +3, +5, and +7 are considered to be 
hypervalent. That is, the iodine atom has expanded beyond the normal octet of valence 
electrons. When the iodine atom has an oxidation state of +3, +5, or +7 it has ten, twelve, 
or fourteen valence electrons, respectively. These hypervalent iodine species not only vary 
in the number of valence electrons (N) of the central atom (X), in this case (I), as stated, 
2 
 
but also the number of ligands (L) and their chemical properties. According to the Martin 
Arduengo N-X-L designation, four general structures for hypervalent iodine species (101-
104), shown below, are considered to be the most important for organic chemistry.1 The 
first two species, 8-I-2 (101) and 10-I-3 (102) are known as iodinanes, which are 
considered trivalent iodine derivatives and will be the focus of this review. The last two 
species, 10-I-4 (103) and 12-I-5 (104) are known as periodinanes are representative of the 
most common structural types for pentavalent iodine derivatives.1 
 
 
Figure 1: Some structures of hypervalent iodine species with Martin-Arduengo 
classification.2 
 
In the hypervalent bonding model, shown in Figure 2, which is the best explanation 
for iodine (III) species, discussed by Musher in 19693 and more recently by Martin4, only 
non-hybridized 5p orbitals of the iodine atom participate in bonding. The iodine atom is 
bound to the least electronegative carbon ligand by a normal covalent bond to the singly 
occupied equatorial 5p orbital, while each of the other two ligands is bound, one per lobe, 
to the axial doubly occupied 5p orbital of the iodine atom. This results in a linear three-
carbon, four-electron (3c-4e) bond that is considered to be a “hypervalent” bond. These 
bonds are weaker and longer than normal covalent bonds. This is a result of the lone pair 
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of electrons in the bonding and non-bonding molecular orbitals that are delocalized to the 
ligands. Due to this delocalization, a charge distribution is created in which the iodine atom 
has an approximate charge of +1 while each ligand has an approximate charge of -1/2. For 
these reasons, trivalent iodine species tend to have a distorted T-shaped geometry. The 
longer and weaker covalent bonds, that are considered to be hypervalent bonds, provide 
important reactive character to trivalent iodine species. 
 
 
Figure 2: Hypervalent bonding model of hypervalent iodine. 
 
Due to the features of iodine, and hypervalent iodine, already mentioned 
hypervalent iodine compounds have seen a resurgence in recent years. This is because their 
high reactivity, benign environmental character, and commercial availability makes them 
appealing and affordable alternatives to expensive and toxic transition metals. Hypervalent 
iodine compounds have application for a variety of reactions, such as C-C bond formation, 
oxidations, iodinations, ligand transfer reactions, and many others.2 
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(Dichloroiodo)benzene (105 in Figure 3) was the first hypervalent iodine 
compound to be synthesized in 1886 by Willgerodt.5 Since then, many other hypervalent 
iodine compounds have been synthesized, such as (diacetoxyiodo)benzene (DIB, 106 in 
Figure 3), in 1892 by Willgerodt,6 and hydroxyl(tosyloxy)iodobenzene (Koser’s reagent 
or HTIB, 107 in Figure 3), are just two, of many, other λ3-iodanes. In the IUPAC 
nomenclature λn notation is used for the designation of a heteroatom in a non-standard 
valence state n. Two examples of popular λ5-iodanes are 2-iodoxybenzoic acid (IBX, 108 
in Figure 3), first synthesized in 1893 by Hartmann and Meyer,7 and Dess-Martin 
periodinane (DMP, 109 in Figure 3), first synthesized in 1983 by Dess and Martin.8 
 
 
Figure 3: Examples of common λ3-iodanes and λ5-iodanes. 
 
In addition to IBX 108 and DMP 109, a wide array of heterocyclic 
organohypervalent iodine compounds have been synthesized and used for organic 
synthesis. Benziodoxoles (Scheme 1) are five-membered hypervalent iodine (III) reagents 
that have been used as efficient electrophilic atom-transfer reagents in the conversion of a 
variety of organic substrates. 
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Scheme 1: Examples of benziodoxoles. 
 
Azidations9,10 and amidations11 are examples of some of these transformations (Scheme 
2).  In 1996, Zhdankin and co-workers demonstrated that 110 could be reacted with N,N-
dimethyl aniline, under reflux conditions, to obtain the corresponding product of C-H 
azidation (Scheme 2a).9 In 2015, Zhdankin and co-workers demonstrated that 110 could 
be reacted with aldehydes to yield acyl azides which could be further reacted to produce 
carbamates (Scheme 2b).10  In 1997, Zhdankin and co-workers demonstrated that the 
amidation product of N,N-dimethyl aniline could be obtained following its reaction with 
111 under reflux conditions (Scheme 2c).11 It should be noted that the transformations 
mentioned are a result of benziodoxoles with exocyclic nitrogen ligands. 
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Scheme 2: Azidation and amidation reactions using benziodoxoles with exocyclic nitrogen 
ligands. 
 
As shown in Figure 4 below, a number of bicyclic benziodoxoles have been 
reported. The preparation of iodosodilactone, 112, was first prepared by Agosta in 1965.12 
In 2012, Zhang and co-workers reported a different method for the preparation of 112, 
confirmed its structure, and tested its reactivity.13 Zhang and co-workers demonstrated that 
112 could be used as an efficient and recyclable coupling reagent for the preparation of 
esters, amides, macrocyclic lactones, and peptides.13 In fact, 112 was used for the solid-
state synthesis of peptides without racemization.13 In 2014, Zhang and co-workers also 
demonstrated that 113 and 114 could be used for the synthesis of dipeptides.14 
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In 2015, Zhang and co-workers demonstrated 115 to be an improvement upon their 
previous reagent, 112, in terms of peptide coupling as it gave higher yields with 
significantly lower reaction times and at room temperature, as opposed to needing to be 
heated. It was also reported that, like 112, 115 can also be regenerated from the reaction 
mixture.15 Furthermore, in 2018 Zhang and co-workers showed that 115 could be used for 
solid-phase peptide synthesis.16 In 1982, Martin and co-workers reported a method for the 
synthesis of 116.17 Later, in 1986, Martin and co-workers reported a method for the 
synthesis of 117, as well as its crystal structure.18 
 
 
Figure 4: Examples of known bicyclic benziodoxoles. 
 
Five-membered hypervalent iodine(III) heterocycles with heteroatoms other than 
oxygen are also known. Among these non-oxygen heteroatoms are phosphorous,19 sulfur,20 
boron,21,22 and nitrogen.23-25 A number of nitrogen containing heterocyclic iodine(III) 
compounds have been reported. 
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2. Results and Discussion: Bicyclic Benziodazole 
2.1 Introduction 
 Esters and amides are critically important functional groups, not only in synthetic 
chemistry but also in everyday life. Parabens are esters that have been used for food 
preservatives,26 millions of tons of polyester are produced annually,27 around one-quarter 
of pharmacological syntheses involve esters,28-30 esters are also commonly used in the 
fragrance industry, and for the synthesis of fatty acids.31 Amide functional groups are 
present in biologically significant compounds such as amino acids, and by extension 
proteins and peptides.32 Amides can also be used as protecting groups or in the synthesis 
of polymers. 
 Due to the importance of esters and amides many procedures have been developed 
for their synthesis. Fischer, Steglich, Mitsunobu, Yamaguchi, Schotten-Bauchmann 
reactions are just some of the many methods used to make esters and amides. 
 
2.2 Preparation 
 The desired bicyclic benziodazole was prepared from commercially available 2-
aminoisophthalic acid in five steps as shown in Scheme 1. The conversion of 2-
aminoisophthalic acid (201) to 2-iodoisophthalic acid (202) occurs in two steps during 
which the iodination of the amino group occurred via a diazonium salt intermediate 
(Scheme 3).33 The carboxylic acid functional groups of the 2-iodoisophthalic acid were 
first converted to acyl chloride functional groups (203) using thionyl chloride (Scheme 
3).34 These acyl chloride functional groups were then converted to amides using amines 
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which yielded the desired benzamide products (204-206, Scheme 3). Lastly, m-CPBA was 
used to oxidize the benzamide to the desired bicyclic benziodazole products (207, 208; 
Scheme 3).34 
 
 
Scheme 3: The synthetic route from 2-aminoisophthalic acid (201) to bicyclic 
benziodazoles (207 and 208). 
 
2.3 Structural Study and Stability 
 The structure of 207 was confirmed by 1H NMR, 13C NMR, HRMS, and X-ray 
crystallography.34 A single crystal X-ray diffraction of 207 (Figure 5) confirmed the 
presence of two covalent bonds, one between the iodine and each nitrogen atom. These 
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bonds had the following bond lengths: I(1)-N(1) = 2.184 (4) Å and I(1)-N(2) = 2.177 (4) 
Å.34 These bond lengths are similar to those previously reported for benziodazoles.9,35-37 
The bond angle between corresponding to N(1)-I(1)-N(2) was confirmed to be 153.90 
(15)o, which is the most bent among the previously reported bicyclic hypervalent iodine 
compounds.13,14,17 Based on the X-ray data 207 has a distorted T-shaped geometry but due 
to an additional intermolecular coordination between the oxygen atom of a neighboring 
atom and the iodine atom the overall geometry of the iodine center is pseudo-square planar. 
The length of this intermolecular coordination can be described as follows: I(1)---O’(1) = 
3.107 (3) Å.34 
 
 
Figure 5: The X-ray crystal structure of N,N’-diisopropyl(benzo)bisiodazole (207). The 
ellipsoids are drawn to the 50% probability level. Selected bond lengths and angles: I(1)-
(C1) 2.040 (4) Å; I(1)-N(1) 2.184 (4) Å; I(1)-N(2) 2.177 (4) Å; N(1)-I(1)-C(1) 76.89 (18)o; 
N(2)-I(1)-C(1) 77.02 (18)o; N(1)-I(1)-N(2) 153.90 (15)o.34 
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It was observed, by 1H NMR that 207, could be stored in CDCl3 or CD3CN at room 
temperature for over a month without any signs of decomposition. 
 
2.4 Bicyclic Benziodazole for Esterification and Amidation 
 2.4.1 Reaction Scope 
 The reactivity of bicyclic benziodazole 207 was then tested. Similar to the bicyclic 
benziodoxole 112 prepared by Zhang,13 207 was used for oxidatively assisted coupling of 
carboxylic acids and alcohols or amines to form the corresponding esters (Figure 6) and 
amides (Figure 7), respectively.34  
 
 
Figure 6: The products of esterification using 207. 
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Figure 7: Product of amidation using 207. 
 
2.4.2 Mechanism 
 The proposed mechanism for the esterification of alcohols with carboxylic acids is 
depicted below in Figure 8. This mechanism is based on the mechanism proposed by 
Zhang and co-workers.13
 
Figure 8: Proposed esterification mechanism using 207. 
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Zwitterion 1, detected by HRMS, was formed by DMAP, acting as a nucleophile, 
having attacked the electrophilic iodine center of 207 which caused a ligand exchange 
between DMAP and one of the amide moieties. Weiss and Zhdankin have reported similar 
aryl iodine(III) species with N-heteroarenes like pyridine and DMAP.38,39 The electrophilic 
iodine center was then attacked by PPh3 which caused DMAP to leave. The result of this 
second ligand exchange was Zwitterion 2 which was detected by HRMS and is a more 
reactive species. Zhang and co-workers reported that from a mixture of 112, n-hexanoic 
acid, 2-phenylethanol, DMAP, and PPh3 in CHCl3 under reflux conditions that a peak at 
m/z =570.03 was detected ESI-mass analysis which corresponds to the analogous 
benziodoxole species [M + NH4]
+.13 The carboxylic acid would then react with Zwitterion 
2 to form the acyloxyphosphonium salt complex after reductive elimination. Then the 
electrophilic carbonyl carbon of the salt complex was attacked by the alcohol and after the 
subsequent reductive elimination and release of triphenylphosphine oxide the ester is 
formed. 
Zhang and co-workers conducted a mechanistic study where a L-menthol, a chiral, 
sterically hindered secondary alcohol, and n-hexanoic acid were reacted with 112, DMAP, 
and PPh3 and the corresponding ester was obtained with retained stereochemistry.
13 This 
supports that the reaction proceeds from the acyloxyphosphonium salt complex 
intermediate. Zhang and co-workers also conducted a mechanistic study using 18O-labelled 
3-phenylpropanol and the previously mentioned conditions. They obtained the 
corresponding 18O-labelled ester and only normal triphenylphosphine oxide, further 
supporting the proposed mechanism.13 
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3. Results and Discussion: Monocyclic Benziodazole 
3.1 Introduction 
 As previously stated, esters and amides are important. After synthesizing the first 
bicyclic benziodazole it was desired to synthesize the corresponding monocyclic analogue 
by the same oxidative process. Once this was done esterifications and an amidation were 
conducted to compare the reactivities. After the esterifications and the amidation were 
conducted, using 501, the library of monocyclic benziodazoles was expanded. 
 
3.2 Preparation 
  The desired monocyclic benziodazoles were prepared from commercially available 
2-iodobenzoic acids in three steps as shown below in Scheme 4. The conversion of the 2-
iodobenzoic acid derivatives to the corresponding acyl chlorides occurred as a result of 
refluxing with thionyl chloride. The acyl chlorides were then converted to the 
corresponding amides using the appropriate amines in combination with triethylamine. 
These benzamides were then oxidized with m-CPBA which yielded the desired monocyclic 
benziodazole products.  
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Scheme 4: The synthesis of various monocyclic benziodazoles from substituted 2-
iodobenzoic acid derivatives. 
 
3.3 Monocyclic Benziodazole for Esterification and Amidation 
 3.3.1 Optimization Study 
 The ability of 501 to function as a coupling reagent for the condensation of alcohols 
with a carboxylic acid moiety present was optimized using 1-pentanol (Table 2). First, the 
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importance of a carboxylic acid additive was tested (Entries 1 and 2). To prevent 
competition between the carboxylic acid additive and the carboxylic acid moiety present 
in 501 m-chlorobenzoic acid was used for the carboxylic acid additive. It was found that 
when a carboxylic acid additive was used the NMR yield was lower (68%, Entry 1) than 
when a carboxylic acid additive was not used (71%, Entry 2).  
Next, the number of equivalents of 501, base (DMAP), and phosphine (PPh3) that 
would provide the highest yield was tested (Entries 2-4, Table 2). In Entry 2, 2.4 
equivalents of 501, DMAP, and PPh3 were used and an NMR yield of 71% was obtained. 
When the number of equivalents of the three components mentioned was decreased to 1.8 
(Entry 3) to NMR yield remained 71%. The number of equivalents of the three 
components was further decreased to 1.2 equivalents the NMR yield increased to 84% 
(Entry 3). It should be noted that the reaction mixture becomes a gel-like consistency upon 
mixing all of the components and stirring. With that in mind, the proposed reason that the 
yield increased as the number of equivalents of the three components were decreased is 
that a more favorable ratio of the three components were made soluble and participated in 
the reaction. This is supported by the fact that the three components are not equally soluble 
in 1-pentanol.  
Based on the previously proposed esterification mechanism using bicyclic 
benziodazole34 we wanted to investigate whether a catalytic amount of DMAP could be 
used. In Entry 5, 0.6 equivalents of DMAP was used while 501 and PPh3 remained at 1.2 
equivalents. Under these conditions and NMR yield of 62% was obtained. From this it was 
concluded that a catalytic amount of base could not be used. Furthermore, if a catalytic 
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amount of base cannot be used then it is likely that the base does more than activate the 
initial iodine(III) species. 
The base that was used was then alternated in Entries 6-10 and compared to Entry 
4. This was done in order to gain a better understanding of the role that the base might play 
as well as what characteristics of the base are important for the reaction. To this end, Table 
3, focuses on the base-varied entries of Table 2, with the exception of Entry 10 of Table 
2, and provides further details about those bases. In all three solvents (H2O, DMSO, and 
MeCN), piperidine is the most basic, Et3N is the second most basic, and pyridine is the 
least basic. Meanwhile, DMAP and DABCO vary in regards to which is more basic than 
the other, depending on the solvent. However, in the case of both H2O and MeCN the 
difference in the basicity values of DMAP and DABCO is not significantly different (the 
difference in their pKaH values is less than one). In MeCN, DABCO is the most 
nucleophilic, piperidine is second, DMAP is third, Et3N is fourth, and pyridine is the least 
nucleophilic. With these trends established, the reasoning behind the proceedings from 
Entry 4 to subsequent Entries 6-10 can be explained. 
Based on the mechanism proposed by Zhang for their benziodoxole reactions13 and 
our group for the bicyclic benziodazole,34 we proceeded from DMAP (Entry 4, Tables 2 
and 3) to DABCO (Entry 6, Tables 2 and 3) as DABCO is a significantly stronger 
nucleophile than DMAP but does not have a significantly different basicity from DMAP. 
We thought that by using a stronger nucleophile that the first ligand exchange would occur 
more favorably and reduce the possibility for equilibrium. However, the yield was reduced 
from 84% (Entry 4, Tables 2 and 3) to 49% (Entry 6, Tables 2 and 3), which brought the 
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importance of the nucleophilicity of the base into question. To test if basicity was the most 
important characteristic Et3N was used next (Entry 7, Tables 2 and 3) as it is more basic 
than DMAP (and DABCO) but does not have a significantly different nucleophilicity in 
comparison to DMAP. The yield improved to 59% (Entry 7, Tables 2 and 3) compared to 
the reaction with DABCO, but was still worse than when DMAP was used, which brought 
the importance of the basicity of the base into question. In order to gain more evidence 
regarding the lack of importance of base nucleophilicity and basicity, piperidine was used 
next (Entry 8, Tables 2 and 3), as it is more basic and nucleophilic than DMAP. In 
accordance with the previously observed results a yield of 57% was obtained. With this 
evidence in mind, pyridine, which is less basic and less nucleophilic than DMAP, was used 
(Entry 9, Tables 1 and 3), and a yield of 91% was obtained, an improvement upon the 
DMAP conditions. This result gave rise to considerations for factors other than just basicity 
and nucleophilicity of the bases that were tested, such as, how soluble the base became in 
the reaction mixture (and overall reaction mixture solubility), aromaticity, and state of 
matter. One possible reason for why DABCO had such a low yield is because it appeared 
as though not all of the solid became a gel-like substance in the reaction mixture, as is 
usually the case with the other bases. This is supported by the trend that, with the exception 
of DMAP, liquid bases provided higher yields than DABCO. Due to DMAP not following 
this trend it is believed that aromaticity, a characteristic shared between DMAP and 
pyridine, is a critically important feature of the base used, likely due to the planarity 
intrinsic to aromatic compounds which would allow for the nucleophile to approach the 
electrophilic iodine center and induce ligand exchange. It is believed that the reason that 
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pyridine provides a higher yield is because of the higher degree of solubility of the reaction 
mixture when it is used as opposed to DMAP. This is supported by the solubility of 501 in 
pyridine. After a variety of organic amine bases were tested, tBuOK, an inorganic base, 
was tested (Entry 10, Table 2). A yield of 9% was obtained which is not surprising as the 
tBuOK did not become solubilized by the reaction mixture. Next, an alternative phosphine 
was tested. 
Again, with the previously proposed mechanisms in mind, an alternative phosphine 
was investigated to see if the yield could be improved. It was believed that a more 
nucleophilic and less sterically bulky phosphine would improve the yield by making, what 
would be the second ligand exchange if the proposed mechanism is correct, more favorable. 
One such phosphine is PBu3. The conformational energy associated with a n-butyl group 
(~1.75 kcal/mol) is less than that for a phenyl group (3.0 kcal/mol).48 Additionally, the 
Tolman cone angle of PBu3, 132
o, is smaller than that of PPh3, 145
o.49 For these reasons, in 
addition to being more nucleophilic than PPh3,
41,45 PBu3 was used (Entry 11, Table 2). 
However, a lower yield of 36% was obtained when PBu3 was used instead of PPh3. It is 
believed that this disparity in yield can be attributed to the moisture sensitivity of PBu3. 
Finally, the need for two nucleophiles to facilitate two ligand exchanges was 
investigated. In Entry 12 (Table 2), the reaction was run without phosphine. The desired 
ester was not detected. This is not surprising as an activated carboxylic acid cannot be 
formed without PPh3. Then, in Entry 13 (Table 2), the reaction was run without a base 
which resulted in a 29% yield. This suggests that a base is not necessary but dramatically 
improves the yield of the reaction. 
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Table 2: Optimization study of the esterification of 1-pentanol with 501.
 
 
Table 3: A focused look at the properties of the bases used in the optimization study of the 
esterification of 1-pentanol with 501. 
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 3.3.2 Reaction Scope 
After the reaction conditions were optimized the reaction scope was explored. Five 
primary alcohols, three secondary alcohols, and one phenol were successfully used for 
esterification reactions (Table 4).  
 
Table 4: Products of esterification using 501. 
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One tertiary alcohol, t-butanol, was used for an esterification reaction but none of the 
corresponding ester was detected by 1H NMR and GCMS. One primary amine was 
successfully used for an amidation reaction (Scheme 5).  
 
 
Scheme 5: Amidation of benzylamine with 501, pyridine, and PPh3 to afford 610. 
 
The majority of the primary alcohols that were used produced the corresponding 
esters in higher yields than did the secondary alcohols that were used. It is believed that 
502 was produced in a low yield due to the ethanol that was used not having been distilled 
so the water present inhibited reactivity. It is believed that 506-506 were produced in lower 
yields due to the increased steric hindrance of secondary alcohols when compared to 
primary alcohols. It is also believed that the reaction with t-butanol did not yield the desired 
ester was due to the steric hindrance of the alcohol. The phenol alcohol, p-cresol, gave the 
corresponding ester, 509, in high yield, 89%, without detection of dearomatization 
products. This was an important result; as it supports that the alcohol attacks the 
electrophilic carbonyl carbon of the aryloxyphosphonium intermediate. Furthermore, the 
dearomatization of phenols upon reaction with hypervalent iodine species have been 
reported.50-52  
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The use of the primary amine, benzylamine, produced the corresponding amide in 
high yield. As expected, given its higher nucleophilicty, benzylamine produced the 
corresponding amide, 510, in higher yield, 86% (Scheme 5), than did the analogous 
esterification using benzyl alcohol, 76% (Table 4).  With this line of reasoning, it would 
be expected that the secondary alcohols would have resulted in higher yields of their 
corresponding esters than the primary alcohols. As this was not the case, it supported the 
reasoning that the steric hindrance of secondary alcohols was the cause of lower yields. 
Furthermore, if the argument regarding nucleophilicity were applied to the case of p-cresol 
it would be expected that it would have a lower yield than both primary and secondary 
alcohols, but this was not the case; the yield was actually the highest among the alcohols, 
and amine, that were used. Some reasons for this could be that due to its aromatic nature it 
is intrinsically planar so it is not as sterically hindered as secondary alcohols, π-interactions 
could be occurring, and that it assists in solubilizing the reaction mixture (a feature that is 
likely not shared by the other alcohols and amine used). 
 
 3.3.3 Mechanism 
 Two possible mechanisms are proposed below (Figures 9 and 10). The first is 
based on the previously proposed mechanism for the analogous esterification with 112 and 
those proposed by Zhang.13  
 
As shown in Figure 9, the electrophilic iodine center iodine center of the trivalent iodine 
compound is attacked by the nucleophilic pyridine. This results in the carboxylate ligand 
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being exchanged with the pyridine. The resulting intermediate Ia is more reactive than 
the initial iodine(III) species. This increased reactivity allows for PPh3 to attack the iodine 
center which causes the pyridine to be released. This results in an even more reactive 
species, intermediate IIa. Intermediate IIa undergoes reductive elimination, going from 
a trivalent iodine species to a monovalent iodine species. The anionic nitrogen of the 
monovalent iodine species deprotonates the alcohol which is serving as the nucleophile 
and attacking the electrophilic carbon of the carboxylate-phosphine intermediate. The 
resulting intermediate then undergoes another reductive elimination producing triphenyl 
phosphine oxide and the desired ester. The amidation reaction mechanism is believed to be 
the same only with an amine being used in the place of an alcohol.  
 
 
25 
 
 
Figure 9: The purposed mechanism for the esterification of alcohols with 501, pyridine, 
and PPh3.  
 
As previously mentioned, Weiss38 and Zhdankin39 reported similar compounds to 
intermediate Ia (Figure 9). The reaction in Scheme 6 was ran, using the procedure 
reported by Zhdankin in 2002,39 in order to support the first mechanism. The subsequent 
reactants were added to allow for the esterification of 1-pentanol to occur (Scheme 6). 
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Scheme 6: Synthesis of pentyl 3-chlorobenzoate (601) by in situ generation of proposed 
intermediate Ia. 
 
The issue with the first mechanism (Figure 9) is that pyridine is less nucleophilic 
than PPh3. It is because of this that the second mechanism (Figure 10) is proposed. 
 
 
Figure 10: The purposed mechanism for the esterification of alcohols with 501, pyridine, 
and PPh3. 
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The second mechanism is also supported by HRMS data that was obtained from a mixture 
of 501 and PPh3. The mixture produced a fragment of [M]=566, which corresponds to 
byproduct Ib. An attempt to isolate intermediate IIb was carried out according to 
Scheme 7, and as shown, the attempt was unsuccessful. Intermediate IIa/Ib was also 
detected in an APCI study with a fragment of [M + H2O]
+
 = 568. 
 
 
Scheme 7: An attempt to isolate intermediate IIb. 
 
 Whether or not ligand exchange between the carboxylate of 501 and an alcohol, 
specifically 1-pentanol, was investigated, as shown in Scheme 8.  
 
 
Scheme 8: Attempted ligand exchange of 501 with 1-pentanol. 
 
In 2017, a similar reaction was reported by Ito and co-workers, who refluxed IBAc with n-
butanol for 15 minutes to produce IBB, as shown in Scheme 9.53 
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Scheme 9: The previously reported ligand exchange of IBAc with n-butanol.53 
 
Noticeably, the reaction conditions shown in Scheme 8 differs from those by Ito and co-
workers as it was not conducted under reflux conditions and it was carried out for 1h, to 
mimic the normal reaction conditions. It is believed that it is due to the lack of reflux 
conditions that the ligand exchange between 501 and 1-pentanol did not occur as there was 
not enough energy in the system. As it did not occur with an alcohol that is more 
nucleophilic than the m-CBA anion, it is even less likely that it would occur with p-cresol. 
This differs from what is typically reported to occur between an iodine(III) species and a 
phenol and is the reason that dearomatizion does not occur. Both of these things support 
that the alcohol attacks the electrophilic carbonyl carbon rather than the electrophilic iodine 
center, as previously mentioned. Furthermore, esterification reactions proceeding by an 
activated carboxylic acid have been reported.13,15,16,30 It is for these reasons that both 
mechanisms (Figures 9 and 10) depict PPh3 being attacked by the carboxylate rather than 
the alcohol. 
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4. Conclusions and Recommendations 
 The first reported bicyclic benziodazoles, 207 and 208, were prepared by the 
methods described.34 It was found that 207 was implemented in the condensation of 
carboxylic acids and alcohols or amines to produce the corresponding esters and amides, 
respectively.34 An advantage of 207 over 112 and 115 is that it has good solubility in 
common organic solvents. After investigating 207, its monocyclic analogue was prepared, 
had its structure confirmed by X-ray crystallography, and its reactivity investigated. 
 The monocyclic benziodazole analogue of 207, 501, was prepared by the methods 
described. Its reactivity was investigated, and it was found to be effective for esterification 
and amidation reactions. It was found that these reactions could be carried out under neat 
conditions at room temperature. It is believed that the reason that 501 is able to do this, 
while 207, is not is because 501 is a more kinetic product, while 207 is a more 
thermodynamic product. The reason that 501 is a more kinetic product, than 207, is due to 
the carboxylate ligand of 501 being a better leaving group than the amide function group 
of 207. After the reactivity of was tested the library of monocyclic benziodazoles was 
expanded. 
 In the future the other monocyclic benziodazoles could have their reactivity 
investigated. This would allow for comparisons to be made amongst the derivatives and an 
understanding of the impact of structural differences could be gained. Other possible 
futures studies could include altering the carboxylate present in 501 to other carboxylates, 
or even amides. 
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5. Experimental Details 
5.1 Chemicals and Equipment 
All reactions were performed with flame-dried glassware. All commercial reagents were 
ACS reagent grade and were used without further purification. Dichloromethane was 
distilled from CaH2 immediately prior to use. Diethyl ether was distilled from 
Na/benzophenone. Melting points were determined in an open capillary tube with a Mel-
temp II melting point apparatus. Infrared spectra were recorded as a KBr pellet on a Perkin-
Elmer 1600 series FT-IR spectrometer. NMR spectra were recorded on a Varian Inova 500 
or 300 MHz NMR are reported in parts per million (ppm). 1H and 13C NMR chemical shifts 
are referenced relative to tetramethylsilane. 
 
5.2 Procedure for the preparation of 2-iodo-N,N’-
diisopropylisophthalamide (204) 
 
To 2-iodoisophthalic acid (203, 580 mg, 0.200 mmol) thionyl chloride (2.0 mL was added). 
The solution was then refluxed for 2.5 h. Then, the solvent was removed under reduced 
pressure to give the crude solid acyl chloride. Next, isopropylamine (590 mg, 1.0 mmol) 
was added at 0 oC to a stirred mixture of the crude acyl chloride (660 mg, 0.200 mmol) in 
MeCN (2.0 mL). Following the addition of isopropylamine the reaction mixture continued 
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to be stirred at 0 oC for 1 h. The solvent was then removed under reduced pressure to give 
a solid residue which was recrystallized from a dichloromethane/hexane solution to afford 
the pure amide 204. Yield 740 mg (90%, 2 steps), isolated as a white solid, mp 259.5-260.4 
oC; IR (neat) cm-1: 3277, 3067, 2970, 2936, 2876, 1645, 1539; 1H NMR (500 MHz, 
CDCl3): δ 7.35 (t, J = 7.1 Hz, 1H), 7.27 (d, J = 7.1 Hz, 2H), 5.79 (d, J = 7.0 Hz, 2H), 4.34-
4.21 (m, 2H), 1.29 (d, J = 7.0 Hz, 12H); 13C NMR (75 MHz, CDCl3): δ 168.8, 144.5, 
128.5, 128.2, 90.7, 42.3, 22.6; HRMS (APCI-positive): calcd for C14H20IN2O2 
([M+H])+: 375.0569, found: 375.0574.34 
 
5.3 Procedure for the Preparation of N,N’-diisopropylbenziodazole (207) 
 
2-iodo-N,N’-diisopropylisophthalamide 204, (670 mg, 0.20 mmol) was added to a solution 
of m-CPBA (830.0 mg, 0.480 mmol) in MeCN (3.0 mL). The reaction mixture was then 
stirred at room temperature for 24 h. After the reaction was completed, the solvent was 
removed under reduced pressure to give a solid residue. Then diethyl ether was added to 
the solid residue to prepare a suspended solution, which was filtered, washed with diethyl 
ether several times, and dried in vacuum to give product 207. Yield 680 mg (91%), isolated 
as a white solid, mp 143.8 °C (decomp.); IR (CH2Cl2) cm-1: 3071, 3039, 2965, 2929, 
2872, 1626, 1584; 1H NMR (500 MHz, CDCl3): δ 8.32 (d, J = 7.1 Hz, 2H), 7.90 (t, J = 7.1 
32 
 
Hz, 1H), 4.41 (sept, J = 6.8 Hz, 2H), 1.41 (d, J = 6.8 Hz, 12H); 13C NMR (75 MHz, 
CDCl3): δ 162.8, 132.7, 132.2, 131.2, 113.1, 46.3, 24.5; HRMS (APCI): calcd for 
C14H18IN2O2 ([M+H])+: 373.0413, found: 373.0398.34 
 
 
Figure 11: The X-ray crystal structure of N,N’-diisopropyl(benzo)bisiodazole (207). The 
ellipsoids are drawn to the 50% probability level.34 
 
Single crystals of product 207 suitable for X-ray crystallographic analysis were obtained 
by slow crystallization from dichloromethane solution. X-ray diffraction data for 207 were 
collected on Rigaku RAPID II Image Plate system using graphite-monochromated Mo Kα 
radiation (λ = 0.71073 Å) at 173 K. The structure was solved by DIRDIF v2008.3[1] and 
refined using SHELXL-2014/7[2]. Crystal data for 207 C14H17IN2O2, orthorhombic, 
space group Pna21, a = 17.695(2) Å, b = 9.0710(10) Å, c = 9.1760(10) Å, α = 90 °, β = 90 
°, γ = 90 °, V = 1472.9(3) Å3, Z = 4, 12610 reflections measured, 3294 unique reflections, 
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2580 I > 2/s(I), 176 parameters, 1 restraints; Flack Parameter 0.04(2); GooF = 1.038, final 
R1 = 0.0223, Rw (all) = 0.0510. CCDC 1821160.34 
 
5.4 Typical Procedure for Esterifications and Amidations with Bicyclic 
Benziodazole 
A mixture of 207 (67 mg, 0.180 mmol) and DMAP (22 mg, 0.180 mmol) in CHCl3 (5.0 
mL) was stirred at reflux for 1 h. Then, 0.210 mmol of carboxylic acid (butyric acid or 
benzoic acid), PPh3 (39 mg, 0.150 mmol), and 0.150 mmol of alcohol (1-pentanol or benzyl 
alcohol) or 0.150 mmol of amine (benzyl amine) were added to the solution. The reaction 
mixture was then stirred at reflux for 24 h. After reaction, saturated aqueous NaHCO3 (5 
mL) was added and the mixture was extracted with dichloromethane. The organic layer 
was dried over anhydrous Na2SO4 and concentrated under reduced pressure. Purification 
by preparative TLC (hexane/ethyl acetate = 1:1) afforded the analytically pure 301, 302, 
303, or 304.34 
 
Benzyl butyrate (301)34 
 
Reaction of butyric acid (19 mg, 0.210 mmol) and benzyl alcohol (16 mg, 0.150 mmol) 
according to the general procedure afforded 24 mg (90%) of product, isolated as a colorless 
oil; IR (neat) cm-1: 3067, 3036, 2966, 2935, 2877, 1738, 1258, 1172; 1H NMR (300 MHz, 
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CDCl3): δ 7.40-7.29 (m, 5H), 5.12 (s, 2H), 2.34 (t, J = 7.4 Hz, 2H), 1.76-1.60 (m, 2H), 
0.95 (t, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 173.5, 136.2, 128.5, 128.2, 66.1, 
36.2, 18.5, 13.7. 
 
Benzyl benzoate (302)34 
 
Reaction of benzoic acid (26 mg, 0.210 mmol) and benzyl alcohol (16 mg, 0.150 mmol) 
according to the general procedure afforded 16 mg (50%) of product, isolated as a colorless 
oil; IR (neat) cm-1: 3090, 3062, 3032, 2954, 1720, 1602, 1452, 1272, 1110, 712; 1H NMR 
(500 MHz, CDCl3): δ 8.08 (d, J = 6.5 Hz, 2H), 7.55 (t, J = 7.5 Hz, 1H), 7.47-7.31 (m, 7H), 
5.37 (s, 2H); 13C NMR (75 MHz, CDCl3): δ 166.4, 136.1, 133.0, 130.2, 129.7, 128.6, 
128.4, 128.2, 128.2, 66.7. 
 
Pentyl Benzoate (303)34 
 
Reaction of benzoic acid (26 mg, 0.210 mmol) and 1-pentanol (13 mg, 0.150 mmol) 
according to the general procedure afforded 16 mg (55%) of product, isolated as a colorless 
oil; IR (neat) cm-1: 3070, 2959, 2933, 2783, 2862, 1722, 1603, 1452, 1274, 1109, 710; 1H 
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NMR (500 MHz, CDCl3): δ 8.08 (d, J = 6.5 Hz, 2H), 7.55 (t, J = 7.5 Hz, 1H), 7.47-7.31 
(m, 7H), 5.37 (s, 2H); 13C NMR (75 MHz, CDCl3): δ 166.9, 134.0, 130.7, 129.5, 128.6, 
65.3, 28.6, 28.4, 22.5, 15.0. 
 
Benzylbutyramide (304)34 
 
Reaction of benzoic acid (26 mg, 0.210 mmol) and 1-pentanol (10b, 13 mg, 0.150 mmol) 
according to the general procedure afforded 16 mg (55%) of product 11c, isolated as a 
colorless oil; IR (neat) cm-1: 3070, 2959, 2933, 2783, 2862, 1722, 1603, 1452, 1274, 1109, 
710; 1H NMR (500 MHz, CDCl3): δ 8.08 (d, J = 6.5 Hz, 2H), 7.55 (t, J = 7.5 Hz, 1H), 
7.47-7.31 (m, 7H), 5.37 (s, 2H); 13C NMR (75 MHz, CDCl3): δ 166.9, 134.0, 130.7, 129.5, 
128.6, 65.3, 28.6, 28.4, 22.5, 15.0. 
 
5.5 Typical Procedure for the Preparation of 2-Iodobenzamides 
To an excess of thionyl chloride, substituted 2-iodobenzoic acid (1 equiv) was added and 
refluxed for 2.5 h. After the reaction was completed the solvent was removed under reduced 
pressure to afford the crude acyl chloride. Dichloromethane was added to the crude acyl 
chloride and cooled to 0 oC. Once cooled, Et3N (2.2 equiv) and the appropriate amine (1.1 
equiv) were slowly added to the reaction mixture. Once addition of the amines was 
completed the reaction continued to be stirred for 1 h. After the reaction was completed 
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water was added to the reaction mixture. The reaction mixture was extracted with 
dichloromethane. The organic layer was dried over anhydrous Na2SO4 and concentrated 
under reduced pressure to afford the pure substituted 2-iodobenzamides. 
 
2-iodo-N-isopropylbenzamide (401)54-56 
 
Reaction of 2-iodobenzoic acid (2.976g, 12 mmol) and thionyl chloride according to the 
general procedure afforded 3.171g (11.9 mmol) of the crude acyl chloride. Reaction of 
3.171g of the acyl chloride the corresponding acyl chloride. Reaction of the acyl chloride 
with isopropylamine (0.774 g, 13.1 mmol) and Et3N (2.649 g, 26.2) according to the 
general procedure afforded 3.325g (97%) of product 401, isolated as a white solid, mp 
136.4-137.7 oC (Lit. 135-136 oC)54; 1H NMR (500 MHz, CDCl3): δ 7.84 (d, J = 8 Hz, 1H), 
7.40-7.34 (m, 2H), 7.08 (t, J = 7.25 Hz, 1H), 5.57 (br. s, 1H), 4.35-4.22 (m, 1H), 4.29 (d, J 
= 6.5 Hz, 6H); HRMS (APCI-positive): calcd for C10H13INO ([M+H])
+: 290.0042, found: 
290.0063. 
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2-Iodo-N-phenylbenzamide (402)55,57-60 
 
Reaction of 2-iodobenzoic acid and thionyl chloride according to the general procedure 
afforded the crude acyl chloride. Reaction of the crude acyl chloride (1.089 g, 4.09 mmol) 
with aniline (419 mg, 4.50 mmol) and Et3N (908 mg, 9.0 mmol) according to the general 
procedure afforded 1.085 g (82%) of product 402, isolated as a tan solid, mp 144.2-145.0 
oC (Lit. 144-146 oC)60; 1H NMR (500 MHz, CDCl3): δ 7.92 (d, J = 8.5 Hz, 1H), 7.64 (d, J 
= 8 Hz, 2H), 7.54 (d, J = 7.5 Hz, 1H), 7.48-7.34 (m, 4H), 7.22-7.11 (m, 2H). 
 
N-ethyl-2-iodobenzamide (403)55,58,61 
 
Reaction of 2-iodobenzoic acid and thionyl chloride according to the general procedure 
afforded the crude acyl chloride. Reaction of the crude acyl chloride (1.062 g, 3.99 mmol) 
with EtNH2•THF (2 M) (1.776 g, 4.38 mmol) and Et3N (0.887 g, 8.77 mmol) according to 
the general procedure afforded 1.085 g (94%) of product 403, isolated as a white solid, 
114.3-115.5 oC (114-116 oC)61; 1H NMR (500 MHz, CDCl3): δ 7.84 (d, J = 7 Hz, 1H), 
7.40-7.32 (m, 2H), 7.12-7.04 (m, 1H), 3.53-3.43 (m, 2H), 1.27 (t, J = 7.75 Hz, 3H). 
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N-(tert-butyl)-2-iodobenzamide (404)55,56,59 
 
Reaction of 2-iodobenzoic acid and thionyl chloride according to the general procedure 
afforded the crude acyl chloride. Reaction of the crude acyl chloride (1.063 g, 3.99 mmol) 
with t-butylamine (321 mg, 4.39 mmol) and Et3N (888 mg, 8.78 mmol) according to the 
general procedure afforded 1.140 g (94%) of product 404, isolated as a white solid, mp 
122.2-124.1 oC (Lit. 120-122 oC)59; 1H NMR (500 MHz, CDCl3): δ 7.82 (d, J =8 Hz, 1H), 
7.40-7.32 (m, 2H), 7.06 (t, J = 7.75 Hz, 1H), 5.55 (br. s, 1H), 1.48 (s, 9H). 
 
N-cyclohexyl-2-iodobenzamide (405)55,58,59,62 
 
Reaction of 2-iodobenzoic acid and thionyl chloride according to the general procedure 
afforded the crude acyl chloride. Reaction of the crude acyl chloride (1.025 g, 3.85 mmol) 
with cyclohexylamine (420 mg, 4.23 mmol) and Et3N (857 mg, 8.46 mmol) according to 
the general procedure afforded 1.201 g (95%) of product 405, isolated as a white solid, mp 
141.2-142.3 oC (Lit. 141-143 oC)59; 1H NMR (500 MHz, CDCl3): δ 7.85 (d, J = 8.5 Hz, 
1H), 7.41-7.33 (m, 2H), 7.08 (t, J = 7 Hz, 1H), 7.08 (t, J = 7 Hz, 1H), 4.05-3.95 (m, 1H), 
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2.13-2.04 (m, 2H), 1.81-1.72 (m, 2H), 1.69-1.60 (m, 1H), 1.49-1.38 (m, 2H), 1.33-1.15 (m, 
3H). 
 
2-iodo-N-isopropyl-3-methylbenzamide (406) 
 
Reaction of 2-iodo-3-methylbenzoic acid and thionyl chloride according to the general 
procedure afforded the crude acyl chloride. Reaction of the crude acyl chloride (1.063g, 
3.79 mmol) with isoprpylamine (224 mg, 4.17 mmol) and Et3N (844 mg, 8.34 mmol) 
according to the general procedure afforded 1.084 g (94%) of product 406, isolated as a 
white solid, mp 135.6-137.2 oC.; IR (neat) cm-1: 3248, 3069, 2970, 2937, 2875, 1657, 1551, 
1459, 1366, 1352, 1331, 1303, 1266, 1204, 1156, 1129, 1012, 919, 858, 805, 780, 738, 
718, 685; 1H NMR (500 MHz, CDCl3): δ 7.28-7.21 (m, 2H), 7.11 (t, J = 4.75 Hz, 1H), 5.50 
(br. s, 1H), 4.29 (sept., J = 5.43 Hz, 1H), 2.48 (s, 3H), 1.28 (d, J = 6 Hz, 2H); 13C NMR 
(75 MHz, CDCl3): δ 169.9, 144.5, 143.1, 130.5, 128.4, 125.2, 99.6, 42.4, 29.4, 22.9; HRMS 
(ESI-positive): calcd for C11H15INO ([M+H])
+: 304.0198, found: 304.0190. 
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2-iodo-N-isopropyl-4-methylbenzamide (407)63 
 
Reaction of 2-iodo-4-methylbenzoic acid and thionyl chloride according to the general 
procedure afforded the crude acyl chloride. Reaction of the crude acyl chloride (1.070g, 
3.81 mmol) with isopropylamine (248 mg, 4.19 mmol) and Et3N (849 mg, 8.38 mmol) 
according to the general procedure afforded 1.118 g (97%) of product 407, isolated as a 
tan solid, mp 117.0-119.0 oC; IR (neat) cm-1: 3305, 3062, 2973, 2927, 1874, 1637, 1598. 
1531, 1484, 1464, 1450, 1389, 1369, 1351, 1329, 1289, 1264, 1178, 1127, 1036, 883, 850, 
831, 821, 805, 601, 570; 1H NMR (500 MHz, CDCl3): δ 763 (s, 1H), 7.20 (d, J = 7 Hz, 
1H), 7.11 (d, J = 8 Hz, 1H), 5.99 (br. s, 1H), 4.19 (octet, J = 6.8 Hz, 1H), 2.29 (s, 3H), 1.24 
(d, J = 6.5 Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 168.5, 141.4, 140.2, 139.6, 92.4, 42.2, 
22.6; HRMS (ESI-positive): calcd for C11H15INO ([M+H])
+: 304.0198, found: 304.0193. 
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2-iodo-N-isopropyl-5-methylbenzamide (408) 
 
Reaction of 2-iodo-5-methylbenzoic acid and thionyl chloride according to the general 
procedure afforded the crude acyl chloride. Reaction of the crude acyl chloride (2.140 g, 
7.63 mmol) with isopropylamine (496 mg, 8.39 mmol) and Et3N (16.79 mg, 8.39 mmol) 
according to the general procedure afforded 2.220 g (96%) of product 408, isolated as a 
tan solid, mp 147.8-148.7 oC (Lit. 147-149 oC); 1H NMR (500 MHz, CDCl3): δ 7.68 (d, J 
= 8.5 Hz, 1H), 7.20 (s, 1H), 6.90 (d, J = 7 Hz, 1H), 4.28 (octet, J = 6.714 Hz, 1H), 2.30 (s, 
3H), 1.28 (d, J = 6.5 Hz, 6H); HRMS (ESI-positive): calcd for C11H15INO ([M+H])
+: 
304.0198, found: 304.0196. 
 
5-bromo-2-iodo-N-isopropylbenzamide (409) 
 
Reaction of 2-iodo-5-bromobenzoic acid and thionyl chloride according to the general 
procedure afforded the crude acyl chloride. Reaction of the crude acyl chloride (1.317 g, 
3.81 mmol) with isopropylamine (248 mg, 4.19 mmol) and Et3N (8.48 mg, 8.38 mmol) 
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according to the general procedure afforded 1.347 g (96%) of product 409, isolated as a 
white solid, mp 187.8-188.5 oC; IR (neat) cm-1: 3255, 3073, 2971, 1642, 1541, 1453, 1083, 
1017, 900, 810, 727; 1H NMR (500 MHz, CDCl3): δ 7.68 (d, J = 7.5 Hz, 1H), 7.50 (s, 1H), 
7.21 (d, J = 8.5 Hz, 1H), 5.57 (br. s, 1H), 4.27 (octet, J = 6.833 Hz, 1H ), 1.29 (d, J = 6.5 
Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 167.0, 144.1, 141.1, 134.0, 131.2, 122.6, 90.4, 
42.4, 22.6; HRMS (APCI-positive): calcd for C10H12BrINO ([M+H])
+: 367.9147, found: 
367.9122. 
 
(410) 
 
Reaction of 2-iodonaphthoic acid and thionyl chloride according to the general procedure 
afforded the crude acyl chloride. Reaction of the crude acyl chloride (0.158 g, 0.500 mmol) 
with isopropylamine (33 mg, 0.550 mmol) and Et3N (111 mg, 1.10 mmol) according to the 
general procedure afforded 0.105 g (62%) of product 410, isolated as a tan solid, mp 191.6-
193.3 oC; IR (neat) cm-1: 3279, 2970, 1642, 1541, 1124, 954, 908, 895, 880, 805, 743; 1H 
NMR (500 MHz, CDCl3): δ 8.38 (s, 1H), 7.86 (s, 1H), 7.84-7.78 (m, 1H), 7.76-7.70 (m, 
1H), 7.55-7.50 (m, 2H), 5.68 (br. s, 1H), 4.40-4.30 (m, 1H), 1.33 (d, J = 6.5 Hz, 6H); 13C 
NMR (75 MHz, CDCl3): δ 168.5, 139.3, 139.0, 134.9, 131.9, 128.1, 127.8, 127.4, 127.3, 
126.6, 88.8, 42.3, 22.7; HRMS (ESI-positive): calcd for C14H15INO ([M+H])
+: 340.0198, 
found: 340.0188. 
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5.6 Typical Procedure for the Preparation of Monocyclic Benziodazoles 
To a solution of substituted 2-iodobenzamide (1.0 equiv) in MeCN, m-CPBA (1.5 equiv) 
was added. The mixture was stirred at room temperature for 12 h. After the reaction was 
completed the solvent was removed under reduced pressure which resulted in a solid. The 
solid was filtered several times with diethyl ether to afford the desired product. 
 
(501) 
 
Reaction of 401 (2.637 g, 9.12 mmol) and m-CPBA (2.361 g, 13.68 mmol) according to 
the general procedure afforded 2.590 g (64%) of product 501, isolated as a white solid, mp 
142.0-142.8 oC; IR (neat) cm-1: 3067, 2967, 2932, 2875, 1627, 1588, 1570, 1296, 1257, 
739; 1H NMR (500 MHz, CDCl3): δ 8.28 (d, J = 8 Hz, 1H), 8.21 (d, J = 6 Hz, 1H), 8.03 (s, 
1H), 7.96 (d, J = 8 Hz, 1H), 7.75 (t, J = 7.75 Hz, 1H), 7.72 (t, J = 7.5 Hz, 1H), 7.53 (d, J = 
7.5 Hz, 1H), 7.40 (t, J = 7.75 Hz, 1H), 4.52 (sept., J = 6.625 Hz, 1H), 1.47 (d, J = 6.5 Hz, 
6H) ; 13C NMR (75 MHz, CDCl3): δ 171.3, 165.9, 134.4, 133.7, 133.6, 132.3, 131.8, 131.0, 
129.9, 129.8, 129.6, 127.9, 116.6, 46.7, 24.3; HRMS (APCI-positive): calcd for 
C17H16ClINO3 ([M+H])
+: 443.9863, found: 443.9877. 
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(502) 
 
Reaction of 402 (750 mg, 2.32 mmol) and m-CPBA (601 mg, 3.48 mmol) in MeCN (17.4 
mL) according to the general procedure afforded 841 mg (76%) of product 502, isolated as 
a tan solid, mp 161.2-163.0 oC (decomp. 154.8 oC); IR (neat) cm-1: 3067, 3033, 1637, 1586, 
1569, 1488, 1441, 1507, 1262, 1125, 754, 741, 659; 1H NMR (500 MHz, CDCl3): δ 8.34 
(d, J = 7.5 Hz, 1H), 8.28 (d, J = 8 Hz, 1H), 8.03 (s, 1H), 7.99-7.88 (m, 2H), 7.78 (t, J = 
7.25 Hz, 1H), 7.58-7.37 (m, 6H), 7.32 (t, J = 6.5 Hz, 1H); 13C NMR (75 MHz, CDCl3): δ 
170.9, 164.5, 138.1, 135.3, 134.4, 132.9, 132.8, 132.610, 132.572, 131.2, 129.9, 129.8, 
129.696, 129.673, 128.0, 127.2, 126.4; HRMS (ESI-positive): calcd for C13H11INO2 ([M-
OAr+H])+: 339.9834, found: 339.9807. 
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(503) 
 
Reaction of 403 (550 mg, 2.00 mmol) and m-CPBA (518 mg, 3.00 mmol) in MeCN (15.0 
mL) according to the general procedure afforded .380 mg (44%) of product 503, isolated 
as a white solid, mp 76.0-78.0 oC; IR (neat) cm-1: 3074, 2969, 2935, 2876, 1627, 1590, 
1571, 1442, 1319, 1263, 756, 739; 1H NMR (500 MHz, CDCl3): δ 8.29 (d, J = 8 Hz, 1H), 
8.23 (d, J = 8 Hz, 1H), 8.04 (s, 1H), 7.96 (d, J = 8 Hz, 1H), 7.86 (t, J = 7.75 Hz, 1H), 7.73 
(t, J = 7.25 Hz, 1H), 7.53 (d, J = 6.5 Hz, 1H), 7.41 (t, J = 7.75 Hz, 1H), 3.76 (q, J = 7.167 
Hz, 2H), 1.36 (t, J = 7 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 171.2, 166.3, 134.8, 134.4, 
133.5, 132.5, 132.4, 131.9, 131.0, 130.0, 129.8, 129.6, 127.9, 116.8, 38.3, 16.1; HRMS 
(ESI-positive): calcd for C9H11INO2 ([M-OAr+H])
+: 291.9834, found: 291.9817. 
 
(504) 
 
Reaction of 404 (606 mg, 2.00 mmol) and m-CPBA (518 mg, 3.00 mmol) in MeCN (15.0 
mL) according to the general procedure afforded 705 mg (77%) of product 504, isolated as 
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a white solid, mp 170.8-172.0 oC; IR (neat) cm-1: 3070, 2966, 1628, 1585, 1570, 1438, 
1317, 1262, 930, 756, 740; 1H NMR (500 MHz, CDCl3): δ 8.26 (d, J = 8.5 Hz, 1H), 8.15 
(d, J = 7.5 Hz, 1H), 8.04 (s, 1H), 7.96 (d, J = 7.5 Hz, 1H), 7.84 (t, J = 7.75 Hz, 1H), 7.71 
(t, J = 7.5 Hz, 2H), 7.52 (d, J = 7 Hz, 1H), 7.40 (t, J = 7.75 Hz, 1H), 1.71 (s, 9H); 13C NMR 
(75 MHz, CDCl3): δ 171.3, 165.8, 135.0, 134.5, 134.4, 133.7, 132.3, 131.8, 130.9, 129.6, 
129.5, 127.9, 114.8, 58.2, 30.2; HRMS (ESI-positive): calcd for C11H15INO2 ([M-
OAr+H])+: 320.0147, found: 320.0137. 
 
(505) 
 
Reaction of 405 (750 mg, 2.28 mmol) and m-CPBA (590 mg, 3.42 mmol) in MeCN (17.1) 
according to the general procedure afforded 633 mg (57%) of product 505, isolated as a 
white solid, mp 159.0-160.3 oC; IR (neat) cm-1: 3071, 2929, 2854, 1629, 1589, 1566, 1439, 
1323, 1294, 1621, 1067, 967, 756, 739, 659; 1H NMR (500 MHz, CDCl3): δ 8.29 (d, J = 8 
Hz, 1H), 8.22 (d, J = 7.5 Hz, 1H), 8.04 (s, 1H), 7.96 (d, J = 7 Hz, 1H), 7.83 (t, J = 7.75 Hz, 
1H), 7.72 (t, J = 7.5 Hz, 1H), 7.52 (d, J = 8.5 Hz, 1H), 7.40 (t, J = 7.75 Hz, 1H), 4.21-4.08 
(m, 1H), 2.25-2.15 (m, 2H), 1.95-1.84 (m, 2H), 1.79-1.70 (m, 1H), 1.48 (pent., J = 10.875 
Hz, 4H), 1.30-1.18(m, 1H); 13C NMR (75 MHz, CDCl3): δ 171.4, 165.9, 134.5, 134.4, 
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133.7, 133.6, 132.3, 131.8, 131.0, 130.0, 129.8, 129.6, 127.8, 116.9, 54.2, 35.5, 25.7, 25.3; 
HRMS (ESI-positive): calcd for C13H17INO2 ([M-OAr+H])
+: 346.0304, found: 346.0286. 
 
(507) 
 
 
Reaction of 407 (606mg, 2.00 mmol) and m-CPBA (518, 3.00 mmol) according to the 
general procedure afforded 486 mg (53%) of product 507, isolated as a tan solid, mp 150.2-
151.5 oC; IR (neat) cm-1: 3073, 2964, 2929, 1618, 1569, 1463, 1313, 1295, 1260, 1143, 
757, 740, 667; 1H NMR (500 MHz, CDCl3): δ 8.09-8.01 (m, 3H), 7.95 (d, J = 7.5 Hz, 1H), 
7.55-7.48 (m, 2H), 7.41 (t, J = 7.75 Hz, 1H), 4.50 (sept, J = 6.6 Hz, 1H), 2.56 (s, 3H), 1.45 
(d, J = 6.5 Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 171.3, 166.1, 146.0, 134.4, 133.8, 132.3, 
132.1, 131.5, 131.0, 129.9, 129.8, 129.6, 127.8, 116.8, 46.6, 24.4, 22.3; HRMS (ESI-
positive): calcd for C11H15INO2 ([M-OAr+H])
+: 320.0147, found: 320.0140. 
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(508) 
 
Reaction of 408 (606 mg, 2.00 mmol) and m-CPBA (518 mg, 0.150 mmol) in MeCN (15.0 
mL) according to the general procedure afforded 513 mg (56%) of product 508, isolated as 
a white solid, mp 148.0-15.0 oC; IR (neat) cm-1: 3067, 2965, 2927, 2874, 1630, 1574, 1456, 
1307, 1260, 1143, 756, 740; 1H NMR (500 MHz, CDCl3): δ 8.11 (d, J = 8 Hz, 1H), 8.03 
(s, 2H), 7.64 (d, J = 6.5 Hz, 1H), 7.52 (d, J = 7.5 Hz, 1H), 7.40 (t, J = 7.75 Hz, 1H), 4.50 
(sept, J = 6.375 Hz, 1H), 2.54 (s, 3H), 1.45 (d, J = 6.5 Hz, 6H); 13C NMR (75 MHz, CDCl3): 
δ 171.2, 166.1, 141.9, 135.6, 134.3, 133.7, 133.4, 132.3, 132.2, 129.8, 129.605, 129.551, 
127.9, 112.8, 46.7, 24.3, 20.9; HRMS (ESI-positive): calcd for C11H15INO2 ([M-
OAr+H])+: 320.0147, found: 320.0141. 
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(509) 
 
Reaction of 409 (736 mg, 2.00 mmol) and m-CPBA (518 mg, 3.00 mmol) in MeCN (15.0 
mL) according to the general procedure afforded 738 mg (71%) of product 11a, isolated as 
a white solid, mp 151.6-152.6 oC; IR (neat) cm-1: 3103, 3066, 2968, 2931, 1636, 1617, 
1568, 1557, 1464, 1443, 1405, 1305, 1260, 1141, 1070, 959, 903, 813, 755, 742; 1H NMR 
(500 MHz, CDCl3): δ 8.34 (s, 1H), 8.13 (d, J = 8.5 Hz, 2H), 8.01 (s, 1H), 7.93 (d, J = 9 Hz, 
2H), 7.53 (d, J = 7.5 Hz, 1H), 7.41 (t, J = 7.75 Hz, 1H), 4.50 (sept, J = 6.25 Hz, 1H), 1.46 
(d, J = 6.5 Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 171.3, 164.5, 137.4, 134.7, 133.3, 132.5, 
131.4, 129.8, 129.7, 127.8, 126.4, 114.5, 46.962; HRMS (ESI-positive): calcd for 
C10H12BrINO2 ([M-OAr+H])
+: 383.9096, found: 383.9101. 
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(510) 
 
Reaction of 410 (85 mg, 0.250 mmol) and m-CPBA (65 mg, 0.375 mmol) in MeCN (1.9 
mL) according to the general procedure afforded 56 mg (46%) of product 510, isolated as 
a tan solid, mp 153.3-155.0 oC; IR (neat) cm-1: 3058, 2966, 2922, 1636, 1619, 1569, 1296, 
1144, 758, 740; 1H NMR (500 MHz, CDCl3): δ 8.74 (s, 2H), 8.15- (d, J = 8.5 Hz, 2H), 8.01 
(s, 1H), 7.93 (d, J = 9 Hz, 2H), 7.53 (d, J = 7.5 Hz, 1H), 7.41 (t, J = 7.75 Hz, 1H), 4.50 
(sept, J = 6.25 Hz, 1H), 1.46 (d, J = 6.5 Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 171.3, 
164.5, 137.4, 134.7, 133.3, 132.5, 131.4, 129.8, 129.7, 127.8, 126.4, 114.5, 46.962; HRMS 
(ESI-positive): calcd for C10H12BrINO2 ([M-OAr+H])
+: 383.9096, found: 383.9101. 
 
5.7 Typical Procedure for Esterification and Amidation with Monocyclic 
Benziodazoles 
To a test tube containing 501 (80 mg, 0.18 mmol), PPh3 (47 mg, 0.18 mmol), pyridine (14 
mg, 0.18 mmol), and alcohol (0.15 mmol) or amine (0.15 mmol) were added. The mixture 
was then stirred at room temperature for 1 h. After the reaction was completed, 
dichloromethane (3.0 mL) was used to transfer the reaction mixture to a separatory funnel. 
Then saturated NaHCO3 (3.0 mL) was added and the reaction mixture was extracted with 
dichloromethane. The organic layer was dried over anhydrous Na2SO4 and concentrated 
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under reduced pressure. Purification by preparative TLC (hexane/ethyl acetate = 3:1) 
afforded the analytically pure 601-610. 
Pentyl 3-chlorobenzoate (601)64 
 
Reaction of 1-pentanol (13 mg, 0.150 mmol) according to the general procedure afforded 
29 mg (85%) of product 601, isolated as a colorless oil; IR (neat) cm-1: 2961, 1724, 1576, 
1469, 1293, 1256, 1127, 967, 675; 1H NMR (500 MHz, CDCl3): δ 8.01 (s, 1H), 7.93 (d, J 
= 8 Hz, 1H), 7.52 (d, J = 8 Hz, 1H), 7.41-7.35 (m, 1H), 4.32 (t, J = 6.5 Hz, 2H), 1.82-1.73 
(m, 2H), 1.47-1.34 (m, 4H), 0.94 (t, J = 6.75 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 165.4, 
134.5, 132.8, 132.3, 129.643, 129.612, 127.7, 65.6, 28.4, 28.2, 22.4, 14.0; HRMS (APCI-
positive): calcd for C12H17ClO2 ([M+H])
+: 227.0839, found: 227.0846. 
 
Ethyl 3-chlorobenzoate (602)65 
 
Reaction of ethanol (7 mg, 0.150 mmol) according to the general procedure afforded 13 
mg (47%) of product 11a, isolated as a colorless oil; IR (neat) cm-1: 2924, 1727, 1573, 
1466, 1370, 1293, 1281, 1256, 915, 749; 1H NMR (500 MHz, CDCl3): δ 8.02 (s, 1H), 7.93 
(d, J = 8 Hz, 1H), 7.53 (d, J = 7 Hz, 1H), 7.40-7.36 (m, 1H), 4.39 (q, J = 7.2 Hz, 2H), 1.40 
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(q, J = 7.2 Hz, 3H); HRMS (APCI-positive): calcd for C9H10ClO2 ([M+H])
+: 185.0369, 
found: 185.0389. 
 
Benzyl 3-chlorobenzoate (603)66 
 
Reaction of benzyl alcohol (16 mg, 0.150 mmol) according to the general procedure 
afforded 28 mg (76%) of product 603, isolated as a colorless oil; IR (neat) cm-1: 2955, 
1721, 1576, 1429, 1290, 1278, 1124, 955, 659; 1H NMR (500 MHz, CDCl3): δ 8.06-8.02 
(m, 1H), 7.95 (d, J = 7.5 Hz, 1H), 7.52 (d, J = 7.5 Hz, 1H), 7.44 (d, J = 8.5 Hz, 2H), 7.42-
7.33 (m, 4H), 5.36 (s, 2H); 13C NMR (75 MHz, CDCl3): δ 165.2, 135.6, 134.5, 133.1, 
131.9, 129.734, 129.696, 128.7, 128.4, 128.3, 127.8, 67.1; HRMS (ESI-positive): calcd for 
C14H11ClO2Na ([M+Na])
+: 269.0345, found: 269.0341. 
 
5-Phenylpentyl 3-chlorobenzoate (604) 
 
Reaction of 5-phenyl-1-pentyl alcohol (25 mg, 0.150 mmol) according to the general 
procedure afforded 23 mg (51%) of product 604, isolated as a colorless oil; IR (neat) cm-
1: 2937, 1724, 1576, 1429, 1293, 1256, 1124, 958, 699, 675, 659; 1H NMR (500 MHz, 
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CDCl3): δ 7.99 (s, 1H), 7.90 (d, J = 7.5 Hz, 1H), 7.51 (d, J = 8 Hz, 1H), 7.36 (td, J = 3 Hz, 
J = 7.75 Hz, 1H), 7.28-7.22 (m, 2H), 7.20-7.12 (m, 3H), 4.31 (td, J = 3 Hz, J = 6.625 Hz, 
2H), 2.68-2.58 (m, 2H), 1.85-1.75 (m, 2H), 1.74-1.64 (m, 2H), 1.53-1.42 (m, 2H); 13C 
NMR (75 MHz, CDCl3): δ 164.2, 141.1, 133.2, 131.6, 131.0, 128.415, 128.369, 127.141, 
127.065, 126.4, 124.5, 64.1, 34.5, 29.8, 27.3, 24.3; HRMS (APCI-positive): calcd for 
C18H20ClO2 ([M+H])
+: 303.1152, found: 303.1173. 
 
Methyl 3-chlorobenzoate (605)67,68 
 
Reaction of methanol (5 mg, 0.150 mmol) according to the general procedure afforded 18 
mg (70%) of product 11a, isolated as a colorless oil; 1H NMR (500 MHz, CDCl3): δ 8.02 
(s, 1H), 7.93 (d, J = 7 Hz, 1H), 7.53 (d, J = 8 Hz, 1H), 7.41-7.36 (m, 1H), 3.93 (s, 3H); 13C 
NMR (75 MHz, CDCl3): δ 165.9, 134.5, 132.9, 131.8, 129.7, 129.7, 127.7, 52.4. 
 
1-Phenylethyl 3-chlorobenzoate (606)69 
 
Reaction of 1-phenylethyl alcohol (18 mg, 0.150 mmol) according to the general procedure 
afforded 24 mg (61%) of product 606, isolated as a colorless oil (Lit. mp 134-136 oC)69; 
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IR (neat) cm-1: 2985, 1723, 1574, 1496, 1456, 1428, 1256, 1129, 697; 1H NMR (500 MHz, 
CDCl3): δ 8.04 (s, 1H), 7.96 (d, J = 7.5 Hz, 1H), 7.52 (d, J = 8 Hz, 1H), 7.44 (d, J = 8 Hz, 
1H), 7.41-7.35 (m, 3H), 7.34-7.29 (m, 1H), 6.13 (q, J = 6.5 Hz, 1H), 1.68 (d, J = 6 Hz, 3H); 
13C NMR (75 MHz, CDCl3): δ 164.7, 141.4, 134.5, 133.0, 132.3, 129.7, 129.7, 128.7, 
128.1, 127.9, 126.1, 73.5, 22.4; HRMS (ESI-positive): calcd for C15H13ClO2Na ([M+Na])
+: 
283.0502, found: 283.0489. 
 
Isopropyl 3-chlorobenzoate (607)70 
 
Reaction of isopropanol (9 mg, 0.150 mmol) according to the general procedure afforded 
16 mg (54%) of product 607, isolated as a colorless oil; 1H NMR (500 MHz, CDCl3): δ 
8.02-7.99 (m, 1H), 7.92 (d, J = 7.5 Hz, 1H), 7.51 (d, J = 8 Hz, 1H), 7.39-7.34 (m, 1H), 5.25 
(sept, J = 6.5 Hz, 1H), 1.37 (d, J = 6.5 Hz, 6H). 
 
Cyclohexyl 3-chlorobenzoate (608)71 
 
Reaction of cyclohexanol (15 mg, 0.150 mmol) according to the general procedure 
afforded 20 mg (56%) of product 608, isolated as a colorless oil; IR (neat) cm-1: 2937, 
55 
 
1721, 1576, 1469, 1290, 1253, 1124, 945, 749, 678; 1H NMR (500 MHz, CDCl3): δ 8.03-
8.00 (m, 1H), 7.93 (d, J = 8 Hz, 1H), 7.52 (d, J = 8 Hz, 1H), 7.40-7.36 (m, 1H), 5.06-4.99 
(m, 1H), 1.99-1.91 (m, 2H), 1.84-1.75 (m, 2H), 1.64-1.52, (m, 3H), 1.50-1.40 (m, 2H), 
1.39-1.32 (m, 1H); 13C NMR (75 MHz, CDCl3): δ 164.8, 134.4, 132.747, 132.686, 129.6, 
129.6, 127.7, 73.7, 31.6, 25.4, 23.7; HRMS (APCI-positive): calcd for C13H16ClO2 
([M+H])+: 239.0839, found: 239.0843. 
 
p-Tolyl 3-chlorobenzoate (609) 
 
Reaction of p-cresol (16 mg, 0.150 mmol) according to the general procedure afforded 33 
mg (89%) of product 609, isolated as a white solid, mp 75.4-76.0 oC; IR (neat) cm-1: 2925, 
1742, 1578, 1474, 1288, 1251, 1197, 1165, 1106, 811, 743; 1H NMR (500 MHz, CDCl3): 
δ 8.18-8.16 (m, 1H), 8.07 (d, J = 7.5 Hz, 1H), 7.58 (d, J = 8 Hz, 1H), 7.46-7.41 (m, 1H), 
7.22 (d, J = 11 Hz, 1H), 7.08 (d, J = 8 Hz, 1H), 2.37 (s, 3H); 13C NMR (75 MHz, CDCl3): 
δ 164.7, 149.1, 136.3, 135.3, 134.1, 132.0, 130.7, 130.6 130.4, 128.8, 121.8, 21.4; HRMS 
(ESI-positive): calcd for C14H12ClO2 ([M+H])
+: 247.0526, found: 247.0528. 
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N-Benzyl 3-chlorobenzamide (610)72,73 
 
Reaction of benzylamine (16 mg, 0.150 mmol) (16 mg, 0.150 mmol) according to the 
general procedure afforded 32 mg (86%) of product 610, isolated as a white solid, mp 98.0-
99.0 oC (Lit. mp 98.0-99.0 oC)73; 1H NMR (500 MHz, CDCl3): δ 7.73-7.58 (m, 1H), 7.65 
(d, J = 6.5 Hz, 1H), 7.46 (d, J = 7.5 Hz, 1H), 7.38-7.27 (m, 6H), 6.44 (br. s, 1H), 4.63 (d, 
J = 5.5 Hz, 1H); 13C NMR (75 MHz, CDCl3): δ 165.987, 137.8, 136.1, 134.8, 131.6, 129.9, 
128.8, 127.950, 127.8, 127.3, 125.0, 44.3; HRMS (APCI-positive): calcd for C14H13ClNO 
([M+H])+: 246.0686, found: 246.0706. 
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